United States · FDA National Drug Code directory
LOFEXIDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85789-901_6fe500eb-c442-4dd5-8d38-7568028628d3
- Product NDC
- 85789-901
- Form
- TABLET, FILM COATED
- Composition / generic term
- lofexidine hydrochloride
- Labeler
- BioCorRx Pharmaceuticals Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260815
- Source listing expiry
- 20271231
Source-listed ingredients
- LOFEXIDINE HYDROCHLORIDE — .2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 36 TABLET, FILM COATED in 1 BOTTLE (85789-901-36) · 85789-901-36
- 96 TABLET, FILM COATED in 1 BOTTLE (85789-901-96) · 85789-901-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →